Related Experiment Video
Updated: Jul 16, 2026
12:04
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Neuroendocrine tumors. Biotherapy
1Interdisziplinäres Stoffwechsel-Centrum, Med. Klinik m. S. Hepatologie und Gastroenterologie, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, 13353 Berlin, Germany. ursula.ploeckinger@charite.de
Summary
This review details neuroendocrine tumor classification and biotherapy, including somatostatin analogs and interferon-alpha. It covers treatment efficacy for symptom control and tumor growth, alongside potential side effects.
Area of Science:
- Oncology
- Endocrinology
Background:
- Neuroendocrine tumors (NETs) require precise classification and staging for effective therapeutic strategies.
- Biotherapy, including somatostatin analogs and interferon-alpha, plays a crucial role in managing NETs.
Purpose of the Study:
- To provide an overview of NET classification and staging.
- To discuss the indications, mechanisms, and clinical applications of biotherapy for NETs.
- To evaluate the symptomatic and antiproliferative outcomes and side effects of biotherapy.
Main Methods:
- Review of existing literature on neuroendocrine tumor classification, staging, and biotherapy.
- Analysis of data regarding the efficacy and safety of somatostatin analogs and interferon-alpha therapy.
Main Results:
- Classification and staging systems directly impact prognostic assessment and treatment choices for NETs.
- Biotherapy, particularly somatostatin analogs and interferon-alpha, demonstrates efficacy in symptomatic and antiproliferative treatment.
- Understanding the mechanism of action is key to optimizing biotherapy outcomes.
Conclusions:
- Accurate classification and staging are fundamental for guiding therapeutic decisions in neuroendocrine tumors.
- Biotherapy offers valuable treatment options for managing NETs, addressing both symptoms and tumor progression.
- Further research into biotherapy mechanisms and side effect management can enhance patient care.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...